Long-Term Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate In Patients With Moderate To Severe COPD: The Augment COPD Extension Trial

被引：0
|
作者：
Rennard, S. I. [1 ]
D'Urzo, A. D. [2 ]
Donohue, J. F. [3 ]
He, T. [4 ]
Shrestha, P. [4 ]
Leselbaum, A. [5 ]
Caracta, C. [4 ]
机构：
[1] Univ Nebraska Med Ctr, Omaha, NE USA
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ N Carolina, Chapel Hill, NC USA
[4] Forest Res Inst, Jersey City, NJ USA
[5] Almirall SA, Barcelona, Spain
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2014年 / 189卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6008
引用
收藏
页数：1
相关论文
共 50 条
  • [11] Cardiovascular Safety Of Fixed-Dose Combination Aclidinium Bromide/formoterol Fumarate: Results Of Two 6-Month Studies In Patients With Moderate To Severe COPD
    Donohue, J. F.
    D'Urzo, A. D.
    Singh, D.
    Mergel, V.
    Molins, E.
    Shrestha, P.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [12] Efficacy And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination In A Pooled Population Of Patients With COPD, Stratified By Age
    Mroz, R. M.
    Scanlon, P.
    Donohue, J. F.
    Molins, E.
    Lakkis, H.
    De Miquel, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [13] Lung Function And Safety Of Aclidinium Bromide/formoterol Fumarate Fixed-Dose Combination: Results Of A 1-Year Trial In Patients With COPD
    Make, B. J.
    Donohue, J. F.
    Soong, W.
    Zhong, X.
    Leselbaum, A.
    Caracta, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [14] Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base
    D'Urzo, Anthony D.
    Singh, Dave
    Donohue, James F.
    Chapman, Kenneth R.
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [15] One-year efficacy of aclidinium/formoterol fixed-dose combination in COPD patients: The AUGMENT COPD study
    D'Urzo, Anthony
    Rennard, Stephen
    Kerwin, Edward
    Mergel, Victor
    He, Thomas
    Leselbaum, Anne
    Caracta, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [16] Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date
    Moitra, Subhabrata
    Bhome, Arvind B.
    Brashier, Bill B.
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 1989 - 1999
  • [17] Effect of aclidinium bromide/formoterol fumarate fixed-dose combination (FDC) on exacerbations in moderate-to-severe COPD: Pooled analysis of two studies
    Bateman, Eric
    Rennard, Stephen
    Jones, Paul
    Molins, Eduard
    Jin, Man
    Leselbaum, Anne
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [18] Efficacy and tolerability of aclidinium bromide/formoterol fumarate fixed-dose combination in patients with COPD: A 1-year study
    Make, Barry
    Donohue, James
    Soong, Weily
    Zhong, Xiaoyun
    Leselbaum, Anne
    Caracta, Cynthia
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [19] EFFICACY AND SAFETY OF ACLIDINIUM/FORMOTEROL FIXED-DOSE COMBINATION IN PATIENTS WITH COPD, STRATIFIED BY ICS USE
    Singh, D.
    D'Urzo, A.
    Garcia Gil, E.
    THORAX, 2015, 70 : A36 - A37
  • [20] Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study
    D'Urzo, Anthony D.
    Rennard, Stephen I.
    Kerwin, Edward M.
    Mergel, Victor
    Leselbaum, Anne R.
    Caracta, Cynthia F.
    RESPIRATORY RESEARCH, 2014, 15
12345